sulfamethoxazole has been researched along with Cholera Infantum in 20 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Norfloxacin has been compared to placebo (136 patients), sulfamethoxazole plus trimethoprim (SXT, 72 patients) and oral vancomycin plus colistin (V/C, 61 patients) for the prevention of alimentary tract-associated infections during and after induction chemotherapy." | 2.66 | The tolerability profile of prophylactic norfloxacin in neutropenic patients. ( Corrado, ML; Hesney, M; Struble, WE, 1988) |
| "The cause of AIDS is unknown." | 1.27 | Infectious complications of the acquired immune deficiency syndrome. ( Armstrong, D; Gold, JW, 1984) |
| "Norfloxacin was least active against Clostridium difficile (90% minimal inhibitory concentration, 128 micrograms/ml)." | 1.27 | In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens. ( Gadebusch, HH; Shungu, DL; Weinberg, E, 1983) |
| " A significant dose-response effect was found with both amoxicillin and trimethoprim/sulfamethoxazole." | 1.27 | Antibiotic-associated gastrointestinal symptoms in general pediatric outpatients. ( Contardi, R; Flegel, KM; Hutchinson, TA; Kramer, MS; Leduc, DG; Naimark, L, 1985) |
| " Long-term administration does not per se seem to represent an additional hazard provided the dose is the correct one and the hematologic monitoring of the patient is performed regularly." | 1.25 | Adverse reactions to trimethoprim-sulfamethoxazole, with particular reference to long-term therapy. ( Bernstein, LS, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (90.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mokraoui, NR | 1 |
| Ganim, R | 1 |
| Paez, A | 1 |
| Iaccheri, B | 1 |
| Fiore, T | 1 |
| Papadaki, T | 1 |
| Androudi, S | 1 |
| Janjua, S | 1 |
| Bhaila, I | 1 |
| Stephen Foster, C | 1 |
| Gold, JW | 1 |
| Armstrong, D | 1 |
| Shungu, DL | 1 |
| Weinberg, E | 1 |
| Gadebusch, HH | 1 |
| Burt, RA | 1 |
| Bernstein, LS | 1 |
| Neu, HC | 1 |
| Corrado, ML | 1 |
| Struble, WE | 1 |
| Hesney, M | 1 |
| Kramer, MS | 1 |
| Hutchinson, TA | 1 |
| Naimark, L | 1 |
| Contardi, R | 1 |
| Flegel, KM | 1 |
| Leduc, DG | 1 |
| Koch-Weser, J | 1 |
| Sidel, VW | 1 |
| Dexter, M | 1 |
| Parish, C | 1 |
| Finer, DC | 1 |
| Kanarek, P | 1 |
| Salter, AJ | 1 |
| Frisch, JM | 1 |
| Markoff, N | 1 |
| Horka, M | 1 |
| Wahnbeck, D | 1 |
| Hohenauer, L | 1 |
| Tauchnitz, C | 1 |
| Hitchings, GH | 1 |
| Melén, B | 1 |
| Orsten, PA | 1 |
| Garrod, LP | 2 |
| Wegmüller, E | 1 |
1 review available for sulfamethoxazole and Cholera Infantum
| Article | Year |
|---|---|
Folate antagonists as antibacterial and antiprotozoal agents.
Topics: Anti-Bacterial Agents; Antimalarials; Antiprotozoal Agents; Escherichia coli; Folic Acid Antagonists | 1971 |
3 trials available for sulfamethoxazole and Cholera Infantum
| Article | Year |
|---|---|
Review of adverse reactions associated with cinoxacin and other drugs used to treat urinary tract infections.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents, Urinary; Central Nervous System Diseases; Cinoxacin | 1984 |
The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Topics: Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Colistin; Diarrhea; Gastrointestina | 1988 |
[Trimethoprim-sulfamethosazale (Bactrim) in gastroenterology (author's transl)].
Topics: Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Gastrointestinal Diseases; Humans; Sul | 1974 |
16 other studies available for sulfamethoxazole and Cholera Infantum
| Article | Year |
|---|---|
Chest wall abscess and costochondritis due to Salmonella enterica serotype Choleraesuis: a case report.
Topics: Abscess; Aged; Bacteremia; Female; Gastrointestinal Diseases; Humans; Salmonella; Salmonella enteric | 2023 |
Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Topics: Adolescent; Adult; Atovaquone; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse | 2008 |
Infectious complications of the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Bacterial Infections; Cytomegalovirus Infections; Drug Co | 1984 |
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Digestive System; Drug Combinations; Drug Res | 1983 |
Adverse reactions to trimethoprim-sulfamethoxazole, with particular reference to long-term therapy.
Topics: Adult; Aged; Bacterial Infections; Blood Cell Count; Blood Cells; Blood Platelets; Child; Drug Combi | 1975 |
Newer antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cephapirin; Cephradine; Clindamycin; | 1975 |
Antibiotic-associated gastrointestinal symptoms in general pediatric outpatients.
Topics: Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Cloxacillin; Diar | 1985 |
Adverse reactions to sulfisoxazole, sulfamethoxazole, and nitrofurantoin. Manifestations and specific reaction rates during 2,118 courses of therapy.
Topics: Adolescent; Adult; Age Factors; Aged; Body Weight; Drug Eruptions; Eosinophilia; Female; Fever; Gast | 1971 |
The toxicity profile of trimethoprim-sulphamethoxazole after four years of widespread use.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Animals; Anti-Infective Agents; Child; Child, Presch | 1973 |
Clinical experience with adverse reactions to trimethoprim-sulfamethoxazole.
Topics: Aged; Agranulocytosis; Anemia, Aplastic; Anemia, Macrocytic; Child; Depression; Drug Combinations; D | 1973 |
[Clinical experiences with the combination of trimethoprim and sulfamethoxazol (Bactrim) in pediatric patients].
Topics: Anti-Infective Agents; Bacterial Infections; Child; Child, Preschool; Drug Combinations; Exanthema; | 1972 |
[Experiences with trimethoprim-sulfamethoxazole in the chemotherapy of bacterial infections].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bacteriuria; Bronchiectasis; B | 1970 |
[Results of trimethoprim and sulfamethoxazole therapy in chronic urinary tract infections].
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Drug Resistance, Microbial; Drug Synergism; Exa | 1971 |
[Therapy with trimethoprim-sulfonamide. Clinical results].
Topics: Anti-Infective Agents; Bacterial Infections; Folic Acid Antagonists; Gastrointestinal Diseases; Huma | 1971 |
Clinical applications of trimethoprim-sulphamethoxazole: achievements and prospects.
Topics: Anti-Infective Agents; Drug Synergism; Gastrointestinal Diseases; Gonorrhea; Humans; Microbial Sensi | 1970 |
[Treatment of chronically recurring urinary tract infection with trimethoprim sulfamethoxazole (Eusaprim)].
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Female; Folic Acid Antagonists; Gastrointestina | 1970 |